Hospital Mater Dei SA
BOVESPA:MATD3
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.48
4.95
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MATD3
stock under the Base Case scenario is
7.34
BRL.
Compared to the current market price of 4.86 BRL,
Hospital Mater Dei SA
is
Undervalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Hospital Mater Dei SA.
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
|
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
|
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
|
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
|
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
|
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
|
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
|
| US |
|
Universal Health Services Inc
NYSE:UHS
|
|
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Hospital Mater Dei SA
Balance Sheet Decomposition
Hospital Mater Dei SA
| Current Assets | 1.5B |
| Cash & Short-Term Investments | 638.2m |
| Receivables | 724.4m |
| Other Current Assets | 136.9m |
| Non-Current Assets | 2.8B |
| Long-Term Investments | 12.2m |
| PP&E | 1.5B |
| Intangibles | 731.7m |
| Other Non-Current Assets | 602.5m |
| Current Liabilities | 485m |
| Accounts Payable | 128m |
| Accrued Liabilities | 113.4m |
| Other Current Liabilities | 243.6m |
| Non-Current Liabilities | 2.4B |
| Long-Term Debt | 2B |
| Other Non-Current Liabilities | 386.8m |
Free Cash Flow Analysis
Hospital Mater Dei SA
| BRL | |
| Free Cash Flow | BRL |
Earnings Waterfall
Hospital Mater Dei SA
|
Revenue
|
2.1B
BRL
|
|
Cost of Revenue
|
-1.5B
BRL
|
|
Gross Profit
|
611.2m
BRL
|
|
Operating Expenses
|
-246.3m
BRL
|
|
Operating Income
|
364.9m
BRL
|
|
Other Expenses
|
-235.1m
BRL
|
|
Net Income
|
129.8m
BRL
|
MATD3 Profitability Score
Profitability Due Diligence
Hospital Mater Dei SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Hospital Mater Dei SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
MATD3 Solvency Score
Solvency Due Diligence
Hospital Mater Dei SA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Score
Hospital Mater Dei SA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MATD3 Price Targets Summary
Hospital Mater Dei SA
According to Wall Street analysts, the average 1-year price target for
MATD3
is 5.92 BRL
with a low forecast of 4.55 BRL and a high forecast of 7.35 BRL.
Dividends
Current shareholder yield for
MATD3 is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MATD3
stock under the Base Case scenario is
7.34
BRL.
Compared to the current market price of 4.86 BRL,
Hospital Mater Dei SA
is
Undervalued by 34%.